Skip to main content
David Kwiatkowski, MD, Oncology, Boston, MA

DavidJosephKwiatkowskiMD

Oncology • Boston, MA

Professor of Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Kwiatkowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kwiatkowski's full profile

Already have an account?

  • Office

    20 Shattuck St.
    Boston, MA 02115
    Phone+1 857-307-0781
    Fax+1 617-394-2769

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1979 - 1984
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1986 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1995
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells  
    Darcy A Krueger, David N Franz, David J Kwiatkowski, Kantha Medepalli, Brian J Siroky, Jamie K Capal, Clinical Cancer Research
  • Institutional Implementation of Clinical Tumor Profiling on an Unselected Cancer Population  
    Khanh Do, Lauren L Ritterhouse, William C Hahn, Geoffrey I Shapiro, Barrett J Rollins, Neal I Lindeman, Alanna Church, Geoffrey R Oxnard, Bruce E Johnson, Frank C Kuo,..., The Journal of Clinical Investigation

Lectures

  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3). 
    2019 ASCO Annual Meeting - 6/1/2019

Authored Content

  • Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase InhibitorsJanuary 2018

Press Mentions

  • Study Identifies Genomic Predictors of Outcomes in High-Risk Bladder Cancer
    Study Identifies Genomic Predictors of Outcomes in High-Risk Bladder CancerSeptember 23rd, 2020
  • Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial
    Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialAugust 8th, 2019

Grant Support

  • Mouse Brain Models Of Tuberous SclerosisNational Institute Of Neurological Disorders And Stroke2008–2012
  • Tuberous Sclerosis: Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke2007–2012
  • Tuberous Sclerosis-Pathway And PathogenesisNational Cancer Institute2007–2011
  • Molecular Pathogenesis Of The Hamartoma SyndromesNational Cancer Institute2007–2011
  • Administrative CoreNational Cancer Institute2007–2011
  • The Lymphangioleiomyomatosis (Lam)Genome AtlasNational Heart, Lung, And Blood Institute2009–2010
  • Preclinical Studies Of Rapamycin For TSC Brain DiseaseNational Institute Of Neurological Disorders And Stroke2004–2006
  • Tuberous Sclerosis: Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke2002–2006
  • Genotyping Center For Innate Immunity PGANational Heart, Lung, And Blood Institute2000–2004
  • Gelsolin: Roles In Apoptosis And Tumor DevelopmentNational Heart, Lung, And Blood Institute2001–2003
  • Murine Models Of Tsc1: Mechanisms And TherapiesNational Institute Of Neurological Disorders And Stroke2001–2002
  • Murine Models Of TSC 1: Mechanisms And TherapiesNational Institute Of Neurological Disorders And Stroke2001
  • Tuberous Sclerosis--Mutations And Murine ModelsNational Institute Of Neurological Disorders And Stroke1998–2001
  • Gelsolin--Roles In Apoptosis And Tumor DevelopmentNational Heart, Lung, And Blood Institute2000
  • Actin Regulatory Proteins In Arterial DysfunctionNational Heart, Lung, And Blood Institute1997–1998
  • Gelsolin'S Role In Motility And Host DefenseNational Heart, Lung, And Blood Institute1996–1998
  • Tuberous Sclerosis Gene On 9q34National Institute Of Neurological Disorders And Stroke1994–1997
  • Gelsonlin'S Role In Motility And Host DefenseNational Heart, Lung, And Blood Institute1995
  • International Workshop On Human Chromosome 9National Human Genome Research Institute1994
  • Human Chromosome 9National Human Genome Research Institute1993
  • MAP Of Human Chromosome 9National Human Genome Research Institute1991–1993
  • Molecular Biology Of GelsolinNational Heart, Lung, And Blood Institute1985–1989

Professional Memberships

Dr. David Kwiatkowski, Dr. David Kwiatkowski, MD, Dr. D Kwiatkowski, Dr. David Joseph Kwiatkowski